Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.22
Delayed Data
As of Sep 30
 +0.21 / +2.62%
Today’s Change
5.49
Today|||52-Week Range
9.54
+4.45%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +33.82% increase from the last price of 8.22.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.03
Sales
$61.8M
Reporting Date
Oct 19

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -28.13%
 
 
 
 
 
 
Growthannually 120.83%
 
 
 
 
 
 

Sales

Growthquarterly -2.13%
 
 
 
 
 
 
Growthannually 149.92%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.